Difference between revisions of "FGF14-AS2"
| Line 32: | Line 32: | ||
==References== | ==References== | ||
<references> | <references> | ||
| − | <ref name="ref1"> | + | <ref name="ref1">Yang, F., et al., A novel long non-coding RNA FGF14-AS2 is correlated with progression and prognosis in breast cancer. Biochem Biophys Res Commun, 2016. 470(3): p. 479-483. |
</ref>(1) | </ref>(1) | ||
</references> | </references> | ||
Revision as of 07:02, 15 October 2017
Contents
Annotated Information
Approved Symbol
FGF14-AS2 (FGF14 antisense RNA 2)
FGF14-AS2 expression in breast cancer in validated cohort.[1]
FGF14-AS2 expression in breast cancer in TCGA cohort.[1]
Chromosome
13q33.1
RefSeq ID
NR_036487
RefSeq(supplied by NCBI)
NR_036487
Expression
Compared with adjacent non-cancerous breast tissues, FGF14-AS2 is down-regulated in breast cancer.[1]
| Experiment | Forward primer | Reverse primer |
|---|---|---|
| qRT-PCR | 5'-AGTTCCAGTTACCATCTTCA- 3' | 5'-AGGTTCATAGTTGCCAGAC- 3'[1] |
Function
FGF14-AS2 is involved in the progress of breast cancer and it plays a tumor suppressor gene role.[1]
Disease
breast cancer [1]
Labs working on this lncRNA
- Department of Surgical Oncology, The First Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China.
